| Year |
Citation |
Score |
| 2024 |
Meeker KL, Luckett PH, Barthélemy NR, Hobbs DA, Chen C, Bollinger J, Ovod V, Flores S, Keefe S, Henson RL, Herries EM, McDade E, Hassenstab JJ, Xiong C, Cruchaga C, et al. Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease. Brain Communications. 6: fcae081. PMID 38505230 DOI: 10.1093/braincomms/fcae081 |
0.39 |
|
| 2024 |
Hillerstrom H, Fisher R, Janicki MP, Chicoine B, Christian BT, Esbensen A, Esralew L, Fortea J, Hartley S, Hassenstab J, Keller SM, Krinsky-McHale S, Lai F, Levin J, McCarron M, et al. Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38480678 DOI: 10.1002/alz.13778 |
0.315 |
|
| 2024 |
Wang G, Li Y, Xiong C, Benzinger TLS, Gordon BA, Hassenstab J, Aschenbrenner AJ, McDade E, Clifford DB, Libre-Guerra JJ, Shi X, Mummery CJ, van Dyck CH, Lah JJ, Honig LS, et al. Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38400532 DOI: 10.1002/alz.13735 |
0.356 |
|
| 2024 |
Wang Q, Schindler SE, Chen G, Mckay NS, McCullough A, Flores S, Liu J, Sun Z, Wang S, Wang W, Hassenstab J, Cruchaga C, Perrin RJ, Fagan AM, Morris JC, et al. Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging. Neurology. 102: e208013. PMID 38315956 DOI: 10.1212/WNL.0000000000208013 |
0.376 |
|
| 2024 |
Welhaf MS, Wilks H, Aschenbrenner AJ, Balota DA, Schindler SE, Benzinger TLS, Gordon BA, Cruchaga C, Xiong C, Morris JC, Hassenstab J. Naturalistic assessment of reaction time variability in older adults at risk for Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 1-11. PMID 38282413 DOI: 10.1017/S1355617723011475 |
0.441 |
|
| 2024 |
Wilks H, Benzinger TLS, Schindler SE, Cruchaga C, Morris JC, Hassenstab J. Predictors and outcomes of fluctuations in the clinical dementia rating scale. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38224146 DOI: 10.1002/alz.13679 |
0.334 |
|
| 2023 |
Chen G, McKay NS, Gordon BA, Liu J, Joseph-Mathurin N, Schindler SE, Hassenstab J, Aschenbrenner AJ, Wang Q, Schultz SA, Su Y, LaMontagne PJ, Keefe SJ, Massoumzadeh P, Cruchaga C, et al. Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change? Neuroimage. Clinical. 41: 103551. PMID 38150745 DOI: 10.1016/j.nicl.2023.103551 |
0.396 |
|
| 2023 |
Bonomi S, Lu R, Schindler SE, Bui Q, Lah JJ, Wolk D, Gleason CE, Sperling R, Roberson ED, Levey AI, Shaw L, Van Hulle C, Benzinger T, Adams M, Manzanares C, ... ... Hassenstab J, et al. Relationships of Cognitive Measures with Cerebrospinal Fluid but not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals. Annals of Neurology. PMID 38038976 DOI: 10.1002/ana.26838 |
0.377 |
|
| 2023 |
Tu JC, Millar PR, Strain JF, Eck A, Adeyemo B, Daniels A, Karch C, Huey ED, McDade E, Day GS, Yakushev I, Hassenstab J, Morris J, Llibre-Guerra JJ, Ibanez L, et al. Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease. Biorxiv : the Preprint Server For Biology. PMID 37961586 DOI: 10.1101/2023.10.29.564633 |
0.315 |
|
| 2023 |
Llibre-Guerra JJ, Iaccarino L, Coble D, Edwards L, Li Y, McDade E, Strom A, Gordon B, Mundada N, Schindler SE, Tsoy E, Ma Y, Lu R, Fagan AM, Benzinger TLS, ... ... Hassenstab J, et al. Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 5: fcad280. PMID 37942088 DOI: 10.1093/braincomms/fcad280 |
0.438 |
|
| 2023 |
Gorijala P, Aslam MM, Dang LT, Xicota L, Fernandez MV, Sung YJ, Fan KH, Feingold E, Surace EI, Chhatwal JP, Hom CL, Hartley SL, Hassenstab J, Perrin RJ, Mapstone M, et al. Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37855447 DOI: 10.1002/alz.13506 |
0.425 |
|
| 2023 |
Shirzadi Z, Schultz SA, Yau WW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, Kantarci K, Preboske GM, Jack CR, Farlow MR, Hassenstab J, Jucker M, Morris JC, Xiong C, Karch CM, et al. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. Jama Neurology. PMID 37843849 DOI: 10.1001/jamaneurol.2023.3618 |
0.355 |
|
| 2023 |
Wagemann O, Li Y, Hassenstab J, Aschenbrenner AJ, McKay NS, Gordon BA, Benzinger TLS, Xiong C, Cruchaga C, Renton AE, Perrin RJ, Berman SB, Chhatwal JP, Farlow MR, Day GS, et al. Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37740921 DOI: 10.1002/alz.13460 |
0.387 |
|
| 2023 |
Keleman AA, Nicosia J, Bollinger RM, Wisch JK, Hassenstab J, Morris JC, Ances BM, Balota DA, Stark SL. Precipitating Mechanisms of Falls in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease Reports. 7: 739-750. PMID 37483329 DOI: 10.3233/ADR-230002 |
0.468 |
|
| 2023 |
McKay NS, Gordon BA, Hornbeck RC, Dincer A, Flores S, Keefe SJ, Joseph-Mathurin N, Jack CR, Koeppe R, Millar PR, Ances BM, Chen CD, Daniels A, Hobbs DA, Jackson K, ... ... Hassenstab J, et al. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nature Neuroscience. PMID 37429916 DOI: 10.1038/s41593-023-01359-8 |
0.338 |
|
| 2023 |
Schultz SA, Shirzadi Z, Schultz AP, Liu L, Fitzpatrick CD, McDade E, Barthelemy NR, Renton A, Esposito B, Joseph-Mathurin N, Cruchaga C, Chen CD, Goate A, Allegri RF, Benzinger TLS, ... ... Hassenstab JJ, et al. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. Aging Cell. e13871. PMID 37291760 DOI: 10.1111/acel.13871 |
0.436 |
|
| 2023 |
Luo J, Ma Y, Agboola FJ, Grant E, Morris JC, McDade E, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Gordon BA, Goyal M, Strain JF, Yakushev I, et al. Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Lifespan. Neurology. PMID 37202169 DOI: 10.1212/WNL.0000000000207378 |
0.381 |
|
| 2023 |
Aschenbrenner AJ, Hassenstab J, Morris JC, Cruchaga C, Jackson JJ. Relationships between hourly cognitive variability and risk of Alzheimer's disease revealed with mixed-effects location scale models. Neuropsychology. PMID 37079810 DOI: 10.1037/neu0000905 |
0.44 |
|
| 2023 |
Grober E, Petersen KK, Lipton RB, Hassenstab J, Morris JC, Gordon BA, Ezzati A. Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals. Neurology. PMID 37076305 DOI: 10.1212/WNL.0000000000207276 |
0.36 |
|
| 2023 |
Aschenbrenner AJ, Crawford JL, Peelle JE, Fagan AM, Benzinger TLS, Morris JC, Hassenstab J, Braver TS. Increased cognitive effort costs in healthy aging and preclinical Alzheimer's disease. Psychology and Aging. PMID 37067479 DOI: 10.1037/pag0000742 |
0.358 |
|
| 2023 |
Pettigrew C, Nazarovs J, Soldan A, Singh V, Wang J, Hohman T, Dumitrescu L, Libby J, Kunkle B, Gross AL, Johnson S, Lu Q, Engelman C, Masters CL, Maruff P, ... ... Hassenstab J, et al. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals. Alzheimer's Research & Therapy. 15: 66. PMID 36978190 DOI: 10.1186/s13195-023-01206-9 |
0.385 |
|
| 2023 |
Ying C, Kang P, Binkley MM, Ford AL, Chen Y, Hassenstab J, Wang Q, Strain J, Morris JC, Lee JM, Benzinger TLS, An H. Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementia. Neuroimage. Clinical. 38: 103373. PMID 36933348 DOI: 10.1016/j.nicl.2023.103373 |
0.435 |
|
| 2023 |
Horie K, Li Y, Barthélemy NR, Gordon BA, Hassenstab J, Benzinger TLS, Fagan AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, Ikeuchi T, Kasuga K, Noble J, et al. Change in cerebrospinal fluid tau microtubule binding region detects symptom onset, cognitive decline, tangles, and atrophy in Dominantly Inherited Alzheimer's Disease. Annals of Neurology. PMID 36843330 DOI: 10.1002/ana.26620 |
0.38 |
|
| 2023 |
Xiong C, McCue LM, Buckles V, Grant E, Agboola F, Coble D, Bateman RJ, Fagan AM, Benzinger TLS, Hassenstab J, Schindler SE, McDade E, Moulder K, Gordon BA, Cruchaga C, et al. Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36640138 DOI: 10.1002/alz.12912 |
0.431 |
|
| 2023 |
Millar PR, Gordon BA, Luckett PH, Benzinger TLS, Cruchaga C, Fagan AM, Hassenstab J, Perrin RJ, Schindler SE, Allegri RF, Day GS, Farlow MR, Mori H, Nübling G, Bateman RJ, et al. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study. Elife. 12. PMID 36607335 DOI: 10.7554/eLife.81869 |
0.371 |
|
| 2022 |
Chatterjee P, Vermunt L, Gordon BA, Pedrini S, Boonkamp L, Armstrong NJ, Xiong C, Singh AK, Li Y, Sohrabi HR, Taddei K, Molloy M, Benzinger TLS, Morris JC, Karch C, ... ... Hassenstab J, et al. Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36576155 DOI: 10.1002/alz.12879 |
0.418 |
|
| 2022 |
O'Connor A, Rice H, Barnes J, Ryan NS, Liu KY, Allegri RF, Berman S, Ringman JM, Cruchaga C, Farlow MR, Hassenstab J, Lee JH, Perrin RJ, Xiong C, Gordon B, et al. First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 36522155 DOI: 10.1136/jnnp-2022-329843 |
0.346 |
|
| 2022 |
Boerwinkle AH, Gordon BA, Wisch J, Flores S, Henson RL, Butt OH, McKay N, Chen CD, Benzinger TLS, Fagan AM, Handen BL, Christian BT, Head E, Mapstone M, Rafii MS, ... ... Hassenstab J, et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 22: 55-65. PMID 36517172 DOI: 10.1016/S1474-4422(22)00408-2 |
0.38 |
|
| 2022 |
Aschenbrenner AJ, Li Y, Henson RL, Volluz K, Hassenstab J, Verghese P, West T, Meyer MR, Kirmess KM, Fagan AM, Xiong C, Holtzman D, Morris JC, Bateman RJ, Schindler SE. Comparison of plasma and CSF biomarkers in predicting cognitive decline. Annals of Clinical and Translational Neurology. PMID 36183195 DOI: 10.1002/acn3.51670 |
0.38 |
|
| 2022 |
Hartz SM, Mozersky J, Schindler SE, Linnenbringer E, Wang J, Gordon BA, Raji CA, Moulder KL, West T, Benzinger TLS, Cruchaga C, Hassenstab JJ, Bierut LJ, Xiong C, Morris JC. A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36178120 DOI: 10.1002/alz.12781 |
0.386 |
|
| 2022 |
Jutten RJ, Papp KV, Hendrix S, Ellison N, Langbaum JB, Donohue MC, Hassenstab J, Maruff P, Rentz DM, Harrison J, Cummings J, Scheltens P, Sikkes SAM. Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36086926 DOI: 10.1002/alz.12773 |
0.341 |
|
| 2022 |
Nicosia J, Aschenbrenner AJ, Balota DA, Sliwinski MJ, Tahan M, Adams S, Stout SS, Wilks H, Gordon BA, Benzinger TLS, Fagan AM, Xiong C, Bateman RJ, Morris JC, Hassenstab J. Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 1-13. PMID 36062528 DOI: 10.1017/S135561772200042X |
0.381 |
|
| 2022 |
Luo J, Agboola F, Grant E, Morris JC, Masters CL, Albert MS, Johnson SC, McDade EM, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Wang G, Li Y, et al. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. Brain : a Journal of Neurology. PMID 35925685 DOI: 10.1093/brain/awac238 |
0.433 |
|
| 2022 |
Aschenbrenner AJ, Hassenstab J, Wang G, Li Y, Xiong C, McDade E, Clifford DB, Salloway S, Farlow M, Yaari R, Cheng EYJ, Holdridge KC, Mummery CJ, Masters CL, Hsiung GY, et al. Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials. Frontiers in Aging Neuroscience. 14: 883131. PMID 35783127 DOI: 10.3389/fnagi.2022.883131 |
0.338 |
|
| 2022 |
Vöglein J, Franzmeier N, Morris JC, Dieterich M, McDade E, Simons M, Preische O, Hofmann A, Hassenstab J, Benzinger TL, Fagan A, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, et al. Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35609137 DOI: 10.1002/alz.12684 |
0.341 |
|
| 2022 |
Morris JC, Weiner M, Xiong C, Beckett L, Coble D, Saito N, Aisen PS, Allegri R, Benzinger TLS, Berman SB, Cairns NJ, Carrillo MC, Chui HC, Chhatwal JP, Cruchaga C, ... ... Hassenstab J, et al. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain : a Journal of Neurology. PMID 35580594 DOI: 10.1093/brain/awac181 |
0.45 |
|
| 2022 |
Luckett PH, Chen C, Gordon BA, Wisch J, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, Fox NC, Jucker M, Levin J, Masters CL, Mori H, Noble JM, ... ... Hassenstab J, et al. Biomarker clustering in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35362200 DOI: 10.1002/alz.12661 |
0.375 |
|
| 2022 |
Strain JF, Barthelemy N, Horie K, Gordon BA, Kilgore C, Aschenbrenner A, Cruchaga C, Xiong C, Joseph-Mathurin N, Hassenstab J, Fagan AM, Li Y, Karch CM, Perrin RJ, Berman SB, et al. CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease. Neurobiology of Disease. 168: 105714. PMID 35358703 DOI: 10.1016/j.nbd.2022.105714 |
0.347 |
|
| 2022 |
Morenas-Rodríguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Suárez-Calvet M, Fagan AM, Schultz S, Gordon BA, Benzinger TLS, Hassenstab J, McDade E, Feederle R, Karch CM, Schlepckow K, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study. The Lancet. Neurology. 21: 329-341. PMID 35305339 DOI: 10.1016/S1474-4422(22)00027-8 |
0.481 |
|
| 2022 |
Wang Q, Chen G, Schindler SE, Christensen J, McKay NS, Liu J, Wang S, Sun Z, Hassenstab J, Su Y, Flores S, Hornbeck R, Cash L, Cruchaga C, Fagan AM, et al. Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 35260470 DOI: 10.1212/NXI.0000000000001152 |
0.46 |
|
| 2022 |
McKay NS, Dincer A, Mehrotra V, Aschenbrenner AJ, Balota D, Hornbeck RC, Hassenstab J, Morris JC, Benzinger TLS, Gordon BA. Beta-amyloid moderates the relationship between cortical thickness and attentional control in middle- and older-aged adults. Neurobiology of Aging. 112: 181-190. PMID 35227946 DOI: 10.1016/j.neurobiolaging.2021.12.012 |
0.33 |
|
| 2022 |
Xiong C, Luo J, Schindler SE, Fagan AM, Benzinger T, Hassenstab J, Balls-Berry JE, Agboola F, Grant E, Moulder KL, Morris JC. Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35218143 DOI: 10.1002/alz.12608 |
0.421 |
|
| 2022 |
Lim YY, Maruff P, Barthélemy NR, Goate A, Hassenstab J, Sato C, Fagan AM, Benzinger TLS, Xiong C, Cruchaga C, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, et al. Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease. Jama Neurology. PMID 35099506 DOI: 10.1001/jamaneurol.2021.5181 |
0.34 |
|
| 2022 |
Wilks H, Aschenbrenner AJ, Gordon BA, Balota DA, Fagan AM, Musiek E, Balls-Berry J, Benzinger TLS, Cruchaga C, Morris JC, Hassenstab J. Sharper in the morning: Cognitive time of day effects revealed with high-frequency smartphone testing. Journal of Clinical and Experimental Neuropsychology. 1-13. PMID 35037593 DOI: 10.1080/13803395.2021.2009447 |
0.383 |
|
| 2021 |
Buckles VD, Xiong C, Bateman RJ, Hassenstab J, Allegri R, Berman SB, Chhatwal JP, Danek A, Fagan AM, Ghetti B, Goate A, Graff-Radford N, Jucker M, Levin J, Marcus DS, et al. Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34854530 DOI: 10.1002/alz.12505 |
0.376 |
|
| 2021 |
Hassenstab J, Nicosia J, LaRose M, Aschenbrenner AJ, Gordon BA, Benzinger TLS, Xiong C, Morris JC. Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease. Alzheimer's Research & Therapy. 13: 153. PMID 34517889 DOI: 10.1186/s13195-021-00894-5 |
0.439 |
|
| 2021 |
Öhman F, Hassenstab J, Berron D, Schöll M, Papp KV. Current advances in digital cognitive assessment for preclinical Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12217. PMID 34295959 DOI: 10.1002/dad2.12217 |
0.376 |
|
| 2021 |
Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine. PMID 34155411 DOI: 10.1038/s41591-021-01369-8 |
0.42 |
|
| 2021 |
Harrington KD, Aschenbrenner AJ, Maruff P, Masters CL, Fagan AM, Benzinger TLS, Gordon BA, Cruchaga C, Morris JC, Hassenstab J. Undetected Neurodegenerative Disease Biases Estimates of Cognitive Change in Older Adults. Psychological Science. 956797620985518. PMID 34043464 DOI: 10.1177/0956797620985518 |
0.388 |
|
| 2021 |
Aschenbrenner AJ, Baksh RA, Benejam B, Beresford-Webb JA, Coppus A, Fortea J, Handen BL, Hartley S, Head E, Jaeger J, Levin J, Loosli SV, Rebillat AS, Sacco S, Schmitt FA, ... ... Hassenstab J, et al. Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12184. PMID 33969175 DOI: 10.1002/dad2.12184 |
0.416 |
|
| 2021 |
Ewers M, Luan Y, Frontzkowski L, Neitzel J, Rubinski A, Dichgans M, Hassenstab J, Gordon BA, Chhatwal JP, Levin J, Schofield P, Benzinger TLS, Morris JC, Goate A, Karch CM, et al. Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease. Brain : a Journal of Neurology. PMID 33725114 DOI: 10.1093/brain/awab112 |
0.481 |
|
| 2021 |
Joseph-Mathurin N, Wang G, Kantarci K, Jack CR, McDade E, Hassenstab J, Blazey TM, Gordon BA, Su Y, Chen G, Massoumzadeh P, Hornbeck RC, Allegri RF, Ances BM, Berman SB, et al. Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease. Neurology. PMID 33495373 DOI: 10.1212/WNL.0000000000011542 |
0.301 |
|
| 2021 |
Grober E, Qi Q, Kuo L, Hassenstab J, Perrin RJ, Lipton RB. The Free and Cued Selective Reminding Test Predicts Braak Stage. Journal of Alzheimer's Disease : Jad. PMID 33492287 DOI: 10.3233/JAD-200980 |
0.345 |
|
| 2021 |
Grober E, Qi Q, Kuo L, Hassenstab J, Perrin RJ, Lipton RB. Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes. Journal of Alzheimer's Disease : Jad. PMID 33492286 DOI: 10.3233/JAD-200946 |
0.422 |
|
| 2021 |
Smith R, Strain J, Tanenbaum A, Fagan A, Hassenstab J, Mcdade E, Schindler S, Gordon B, Xiong C, Chhatwal J, Jack CR, Karch C, Berman S, Brosch J, Lah J, et al. Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease. Brain Connectivity. PMID 33430685 DOI: 10.1089/brain.2020.0808 |
0.311 |
|
| 2020 |
Vermunt L, Dicks E, Wang G, Dincer A, Flores S, Keefe SJ, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Fox NC, Ghetti B, Graff-Radford NR, Hassenstab J, Karch CM, et al. Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease. Brain Communications. 2: fcaa102. PMID 32954344 DOI: 10.1093/braincomms/fcaa102 |
0.36 |
|
| 2020 |
Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Neurology. PMID 32873693 DOI: 10.1212/Wnl.0000000000010747 |
0.543 |
|
| 2020 |
Aschenbrenner AJ, Petros J, McDade E, Wang G, Balota DA, Benzinger TL, Cruchaga C, Goate A, Xiong C, Perrin R, Fagan AM, Graff-Radford N, Ghetti B, Levin J, Weidinger E, ... ... Hassenstab J, et al. Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12038. PMID 32587883 DOI: 10.1002/Dad2.12038 |
0.505 |
|
| 2020 |
Stojanovic M, Jin Y, Fagan AM, Benzinger TL, Hassenstab J, Cruchaga C, Morris JC, Head D. Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning. Alzheimer Disease and Associated Disorders. PMID 32520736 DOI: 10.1097/Wad.0000000000000385 |
0.438 |
|
| 2020 |
Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z |
0.451 |
|
| 2020 |
Aschenbrenner AJ, Gordon BA, Fagan AM, Schindler SE, Balota DA, Morris JC, Hassenstab JJ. Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32144992 DOI: 10.3233/Jad-200018 |
0.444 |
|
| 2020 |
Franzmeier N, Koutsouleris N, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Duering M, Dichgans M, Levin J, Gordon BA, Lim YY, Masters CL, Rossor M, Fox NC, ... ... Hassenstab J, et al. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043733 DOI: 10.1002/Alz.12032 |
0.528 |
|
| 2020 |
Teylan M, Mock C, Gauthreaux K, Chen YC, Chan KCG, Hassenstab J, Besser LM, Kukull WA, Crary JF. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy. Brain : a Journal of Neurology. PMID 31942622 DOI: 10.1093/Brain/Awz403 |
0.54 |
|
| 2020 |
Aschenbrenner AJ, James BD, McDade E, Wang G, Lim YY, Benzinger TLS, Cruchaga C, Goate A, Xiong C, Perrin R, Buckles V, Allegri R, Berman SB, Chhatwal JP, Fagan A, ... ... Hassenstab J, et al. Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 219-228. PMID 31914221 DOI: 10.1002/Alz.12010 |
0.395 |
|
| 2019 |
Llibre-Guerra JJ, Li Y, Schindler SE, Gordon BA, Fagan AM, Morris JC, Benzinger TLS, Hassenstab J, Wang G, Allegri R, Berman SB, Chhatwal J, Farlow MR, Holtzman DM, Jucker M, et al. Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease. Jama Network Open. 2: e1917126. PMID 31825500 DOI: 10.1001/jamanetworkopen.2019.17126 |
0.307 |
|
| 2019 |
Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, ... Hassenstab J, et al. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506247 DOI: 10.1016/J.Jalz.2019.06.4955 |
0.555 |
|
| 2019 |
Bos I, Vos SJB, Schindler SE, Hassenstab J, Xiong C, Grant E, Verhey F, Morris JC, Visser PJ, Fagan AM. Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31378575 DOI: 10.1016/J.Jalz.2019.04.015 |
0.517 |
|
| 2019 |
Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, ... ... Hassenstab J, et al. The BDNF SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease. Molecular Psychiatry. PMID 30899092 DOI: 10.1038/S41380-019-0404-6 |
0.494 |
|
| 2019 |
Vöglein J, Paumier K, Jucker M, Preische O, McDade E, Hassenstab J, Benzinger TL, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, Farlow MR, Chhatwal J, Salloway S, Xiong C, et al. Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30897203 DOI: 10.1093/Brain/Awz050 |
0.424 |
|
| 2019 |
Schindler SE, Li Y, Todd KW, Herries EM, Henson RL, Gray JD, Wang G, Graham DL, Shaw LM, Trojanowski JQ, Hassenstab JJ, Benzinger TLS, Cruchaga C, Jucker M, Levin J, et al. Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30846386 DOI: 10.1016/J.Jalz.2018.12.019 |
0.325 |
|
| 2019 |
Wang G, Coble D, McDade EM, Hassenstab J, Fagan AM, Benzinger TLS, Bateman RJ, Morris JC, Xiong C. Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30773445 DOI: 10.1016/J.Jalz.2018.12.008 |
0.456 |
|
| 2019 |
Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, et al. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Brain : a Journal of Neurology. PMID 30753379 DOI: 10.1093/Brain/Awz019 |
0.511 |
|
| 2019 |
Besser LM, Mock C, Teylan MA, Hassenstab J, Kukull WA, Crary JF. Differences in Cognitive Impairment in Primary Age-Related Tauopathy Versus Alzheimer Disease. Journal of Neuropathology and Experimental Neurology. PMID 30715383 DOI: 10.1093/Jnen/Nly132 |
0.479 |
|
| 2019 |
Strain JF, Wisch J, Kilgore CB, McDade E, Li Y, Barthélemy NR, Gordon BA, Hassenstab J, Fagan AM, Morris JC, Benzinger TLS, Bateman R, Ances BM, Dian. Ic‐P‐098: Phosphorylation Of Specific Tau Sites Is Associated With Loss Of White Matter Integrity In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4941 |
0.389 |
|
| 2019 |
Wang G, Aschenbrenner AJ, Li Y, Mcdade E, Liu L, Benzinger TLS, Bateman R, Morris JC, Hassenstab J, Berry S, Xiong C. Two-Period Linear Mixed Effects Primary Analysis Model For Clinical Trials With Run-In Data For Alzheimer Disease Alzheimers & Dementia. 15: 217. DOI: 10.1016/J.Jalz.2019.06.4566 |
0.372 |
|
| 2019 |
Wang G, Lorenzi M, Li Y, Donohue MC, Mcdade E, Aschenbrenner AJ, Benzinger TL, Fagan AM, Schindler SE, Hassenstab J, Berry S, Morris JC, Xiong C, Bateman R. ESTIMATING YEARS FROM CLINICAL SYMPTOM ONSET FOR SPORADIC ALZHEIMER DISEASE: HOW FAR ARE WE? Alzheimer's & Dementia. 15: P216-P217. DOI: 10.1016/J.Jalz.2019.06.4565 |
0.384 |
|
| 2019 |
Wang Q, Dincer A, McCullough AA, Hassenstab J, Gordon BA, Liu J, Morris JC, Benzinger TLS, Wang Y. P4-261: White Matter Vasogenic Edema And Its Association With Neuropsychological Measures In Alzheimer Disease Alzheimers & Dementia. 15: 149. DOI: 10.1016/J.Jalz.2019.06.3930 |
0.44 |
|
| 2019 |
Teylan M, Mock C, Gauthreaux K, Chen Y, Chan KCG, Hassenstab J, Besser LM, Kukull WA, Crary JF. P3-463: Trajectory Of Neuropsychological Test Scores In Mild Cognitive Impairment Comparing Primary Age-Related Tauopathy Versus Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3498 |
0.515 |
|
| 2019 |
Luckett PH, McCullough AA, McCarthy JE, Hassenstab J, Mcdade E, Bateman R, Benzinger TLS, Ances BM. Ic-P-084: Predicting Metabolic And Structural Changes In Dominantly Inherited Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2492 |
0.388 |
|
| 2019 |
Grober E, Wang C, Hassenstab J, Lipton RB. P1-439: THE FREE AND CUED SELECTIVE REMINDING TEST PREDICTS ALZHEIMER'S DISEASE NEUROPATHOLOGY Alzheimer's & Dementia. 15: P434-P434. DOI: 10.1016/J.Jalz.2019.06.1044 |
0.38 |
|
| 2018 |
Wang G, Xiong C, McDade EM, Hassenstab J, Aschenbrenner AJ, Fagan AM, Benzinger TLS, Gordon BA, Morris JC, Li Y, Bateman RJ. Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 669-676. PMID 30569014 DOI: 10.1016/J.Trci.2018.10.009 |
0.563 |
|
| 2018 |
Bussy A, Snider BJ, Coble D, Xiong C, Fagan AM, Cruchaga C, Benzinger TLS, Gordon BA, Hassenstab J, Bateman RJ, Morris JC. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. Neurobiology of Aging. 75: 42-50. PMID 30530186 DOI: 10.1016/J.Neurobiolaging.2018.10.011 |
0.527 |
|
| 2018 |
Javaherian K, Newman BM, Weng H, Hassenstab J, Xiong C, Coble D, Fagan AM, Benzinger T, Morris JC. Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease. Alzheimer Disease and Associated Disorders. PMID 30489279 DOI: 10.1097/Wad.0000000000000284 |
0.429 |
|
| 2018 |
Roe CM, Ances BM, Head D, Babulal GM, Stout SH, Grant EA, Hassenstab J, Xiong C, Holtzman DM, Benzinger TLS, Schindler SE, Fagan AM, Morris JC. Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. Brain : a Journal of Neurology. PMID 30304397 DOI: 10.1093/Brain/Awy244 |
0.467 |
|
| 2018 |
Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith SR, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, et al. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 30272115 DOI: 10.1093/Arclin/Acy078 |
0.485 |
|
| 2018 |
Araque Caballero MÁ, Suárez-Calvet M, Duering M, Franzmeier N, Benzinger T, Fagan AM, Bateman RJ, Jack CR, Levin J, Dichgans M, Jucker M, Karch C, Masters CL, Morris JC, Weiner M, ... ... Hassenstab J, et al. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30239611 DOI: 10.1093/Brain/Awy229 |
0.415 |
|
| 2018 |
McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. PMID 30217935 DOI: 10.1212/Wnl.0000000000006277 |
0.54 |
|
| 2018 |
Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith S, Robertson J, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Rowe CC, et al. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 30149452 DOI: 10.3233/Jad-180507 |
0.501 |
|
| 2018 |
Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. PMID 30068637 DOI: 10.1212/Wnl.0000000000006075 |
0.404 |
|
| 2018 |
Harrington KD, Schembri A, Lim YY, Dang C, Ames D, Hassenstab J, Laws SM, Rainey-Smith S, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, et al. Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease. Neurobiology of Aging. 70: 170-179. PMID 30015036 DOI: 10.1016/J.Neurobiolaging.2018.06.005 |
0.497 |
|
| 2018 |
Lim YY, Hassenstab J, Goate A, Fagan AM, Benzinger TLS, Cruchaga C, McDade E, Chhatwal J, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, Salloway S, Schofield P, et al. Effect of BDNFVal66Met on disease markers in dominantly inherited AD. Annals of Neurology. PMID 30014553 DOI: 10.1002/Ana.25299 |
0.453 |
|
| 2018 |
Wang G, Berry S, Xiong C, Hassenstab J, Quintana M, McDade EM, Delmar P, Vestrucci M, Sethuraman G, Bateman RJ. A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease. Statistics in Medicine. PMID 29761523 DOI: 10.1002/Sim.7811 |
0.485 |
|
| 2018 |
Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Marcus DS, Fagan AM, Jack CR, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. The Lancet. Neurology. PMID 29397305 DOI: 10.1016/S1474-4422(18)30028-0 |
0.472 |
|
| 2018 |
Koenig LN, Keefe S, Marple LM, Blazey T, Gordon BA, Hassenstab J, Morris JC, Miller-Thomas M, Shimony JS, Benzinger TLS. P1-390: Volumetric-Based Diagnosis Of Alzheimer'S Disease Using A Super-Normal Cohort Of Aging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.398 |
0.447 |
|
| 2018 |
Besser LM, Mock C, Teylan M, Hassenstab J, Kukull WA, Crary J. O1-13-03: Cognitive Impairment In Primary Age-Related Tauopathy Versus Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.3043 |
0.512 |
|
| 2018 |
Hassenstab J, Aschenbrenner AJ, Balota DA, McDade E, Lim Y, Fagan AM, Benzinger TLS, Cruchaga C, Goate A, Morris JC, Bateman RJ. O1-04-03: Comparing Smartphone-Administered Cognitive Assessments With Conventional Tests And Biomarkers In Sporadic And Dominantly Inherited Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2350 |
0.5 |
|
| 2018 |
Baker JE, Bruns L, Hassenstab J, Fowler C, Rainey-Smith SR, Ames D, Villemagne VL, Rowe CC, Masters CL, Maruff P, Lim Y. O1-04-01: Preclinical Alzheimer'S Disease Is Associated With Learning Impairments Over Six Days: Results From The Online Repeated Cognitive Assessment (Orca) Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2348 |
0.468 |
|
| 2018 |
Strain JF, Tanenbaum A, Smith RX, Fagan AM, Gordon BA, Hassenstab J, Xiong C, McDade E, Chhatwal JP, Morris JC, Benzinger TLS, Bateman RJ, Ances BM, Dian. Ic-P-043: Functional Architectural Differences Between Autosomal Dominant Alzheimer'S Disease And Late Onset Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2107 |
0.47 |
|
| 2018 |
Smith RX, Tanenbaum A, Strain JF, Gordon BA, Fagan AM, Hassenstab J, McDade E, Xiong C, Chhatwal JP, Morris JC, Benzinger TLS, Bateman RJ, Ances BM. P4-108: Resting-State Functional Connectivity Is Associated With Pathological Biomarkers In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2106 |
0.459 |
|
| 2018 |
Aschenbrenner AJ, Hassenstab J, Wang G, McDade E, Balota DA, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ. P2-499: Alzheimer Disease Biomarkers Predict Differences In Personality: A Cross-Lagged Panel Analysis Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1192 |
0.428 |
|
| 2018 |
Strain JF, Smith RX, Wang Q, Fagan AM, Gordon BA, Hassenstab J, Xiong C, McDade E, Morris JC, Benzinger TLS, Bateman RJ, Ances BM, Dian. P2-464: Biological Correlates Of White Matter Changes In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1157 |
0.438 |
|
| 2018 |
Barthélemy NR, Li Y, Wang G, Fagan AM, Morris JC, Benzinger TLS, Goate A, Hassenstab J, Xiong C, Sato C, Bateman RJ, McDade E. P1-023: Mass Spectrometry-Based Measurement Of Longitudinal Csf Tau Identifies Different Phosphorylated Sites That Track Distinct Stages Of Presymptomatic Dominantly Inherited Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.024 |
0.349 |
|
| 2017 |
Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Martins RN, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Doré V, Villemagne VL, Snyder PJ, Masters CL, Maruff P. Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 156-164. PMID 28761926 DOI: 10.1016/J.Dadm.2017.05.006 |
0.488 |
|
| 2017 |
Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS. A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 147-155. PMID 28653035 DOI: 10.1016/J.Dadm.2017.05.003 |
0.522 |
|
| 2017 |
Schindler SE, Jasielec MS, Weng H, Hassenstab JJ, Grober E, McCue LM, Morris JC, Holtzman DM, Xiong C, Fagan AM. Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease. Neurobiology of Aging. 56: 25-32. PMID 28482211 DOI: 10.1016/J.Neurobiolaging.2017.04.004 |
0.428 |
|
| 2017 |
Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, Maruff P. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 108-121. PMID 28239636 DOI: 10.1016/J.Dadm.2016.09.002 |
0.452 |
|
| 2017 |
Day GS, Lim TS, Hassenstab J, Goate AM, Grant EA, Roe CM, Cairns NJ, Morris JC. Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease. Neurology. PMID 28235814 DOI: 10.1212/Wnl.0000000000003770 |
0.479 |
|
| 2017 |
Bos I, Vos SJ, Hassenstab J, Xiong C, Grant EA, Visser PJ, Morris JC, Fagan AM. ASSOCIATIONS BETWEEN VASCULAR RISK FACTORS AND AD BIOMARKERS IN COGNITIVELY NORMAL INDIVIDUALS Alzheimer's & Dementia. 13: P1506-P1507. DOI: 10.1016/J.Jalz.2017.07.621 |
0.441 |
|
| 2017 |
Xiong C, McCue L, Grant EA, Bateman RJ, Fagan AM, Benzinger TL, Hassenstab J, Buckles V, Moulder KL, Paumier KL, Morris JC. CROSS-SECTIONAL AND LONGITUDINAL COMPARISONS OF COGNITION AND BIOMARKERS AMONG COGNITIVELY NORMAL INDIVIDUALS AGED 42 TO 65 YEARS WITH A FAMILY HISTORY OF EITHER AUTOSOMAL DOMINANT AD (ADAD) OR LATE-ONSET AD (LOAD) Alzheimer's & Dementia. 13: P923. DOI: 10.1016/J.Jalz.2017.07.357 |
0.476 |
|
| 2017 |
Aschenbrenner AJ, Hassenstab J, Gordon BA, Benzinger TL, Morris JC. NEUROIMAGING BIOMARKERS OF THE A/T/N CLASSIFICATION SYSTEM PREDICT CROSS-SECTIONAL AND LONGITUDINAL CHANGE IN PRECLINICAL AND EARLY ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P911. DOI: 10.1016/J.Jalz.2017.07.332 |
0.377 |
|
| 2017 |
McDade E, Wang G, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Hassenstab J, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier KL, Xiong C, Ricardo A, et al. LONGITUDINAL BIOMARKER CHANGES IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE FROM THE DIAN STUDY Alzheimer's & Dementia. 13: P879-P880. DOI: 10.1016/J.Jalz.2017.07.265 |
0.489 |
|
| 2017 |
Xiong C, Wang G, Coble D, Fague S, Fagan AM, Benzinger TL, Hassenstab J, Buckles V, Moulder KL, Paumier KL, Morris JC, Bateman RJ. [P2-209]: QUANTIFYING PRECLINICAL STAGES OF AUTOSOMAL DOMINANT ALZHEIMER DISEASE (ADAD) AND THE ASSOCIATED OVERALL BIOMARKER SIGNATURE ACROSS MODALITIES USING THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN) Alzheimer's & Dementia. 13: P689-P690. DOI: 10.1016/J.Jalz.2017.06.861 |
0.474 |
|
| 2017 |
Lim YY, Hassenstab J, Cruchaga C, Goate AM, Fagan AM, Benzinger TLS, Maruff P, Masters CL, McDade E, Morris JC, Bateman RJ. Bdnf Val66Met Increases Rate Of Memory Decline, Hippocampal Volume Loss And Tau Accumulation In Autosomal Dominant Alzheimer’S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.283 |
0.343 |
|
| 2017 |
Yablonskiy DA, Zhao Y, Cairns NJ, Hassenstab J, Benzinger TL, Astafiev SV, Wen J, Raichle ME, Morris JC. [IC-P-169]: GRADIENT ECHO PLURAL CONTRAST MRI PROVIDES NEW SURROGATE MARKERS OF BRAIN PATHOLOGY IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P127-P128. DOI: 10.1016/J.Jalz.2017.06.2544 |
0.406 |
|
| 2017 |
Gordon BA, Blazey T, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Fagan AM, Marcus DS, Jack CR, et al. [IC-P-054]: EXAMINING LONGITUDINAL NEUROIMAGING PATTERNS IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE: RESULTS FROM THE DOMINANTLY INHERITED ALZHEIMER NETWORK Alzheimer's & Dementia. 13: P44-P45. DOI: 10.1016/J.Jalz.2017.06.2327 |
0.445 |
|
| 2016 |
Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG, Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA. In vivo Detection of Microstructural Correlates of Brain Pathology in Preclinical and Early Alzheimer Disease with Magnetic Resonance Imaging. Neuroimage. PMID 27989773 DOI: 10.1016/J.Neuroimage.2016.12.026 |
0.452 |
|
| 2016 |
Harrington KD, Lim YY, Ames D, Hassenstab J, Rainey-Smith S, Robertson J, Salvado O, Masters CL, Maruff P. Using Robust Normative Data to Investigate the Neuropsychology of Cognitive Aging. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 27932344 DOI: 10.1093/Arclin/Acw106 |
0.425 |
|
| 2016 |
Head D, Allison S, Lucena N, Hassenstab J, Morris JC. Latent structure of cognitive performance in the adult children study. Journal of Clinical and Experimental Neuropsychology. 1-16. PMID 27868476 DOI: 10.1080/13803395.2016.1252725 |
0.505 |
|
| 2016 |
Crane PK, Walker RL, Sonnen J, Gibbons LE, Melrose R, Hassenstab J, Keene CD, Postupna N, Montine TJ, Larson EB. Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes. Neurobiology of Aging. 48: 72-82. PMID 27644076 DOI: 10.1016/J.Neurobiolaging.2016.07.021 |
0.328 |
|
| 2016 |
Bateman RJ, Benzinger TL, Berry S, Clifford DB, Duggan C, Fagan AM, Fanning K, Farlow MR, Hassenstab J, McDade EM, Mills S, Paumier K, Quintana M, Salloway SP, Santacruz A, et al. The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27583651 DOI: 10.1016/J.Jalz.2016.07.005 |
0.407 |
|
| 2016 |
Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, et al. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 27521573 DOI: 10.1093/Brain/Aww200 |
0.484 |
|
| 2016 |
Hassenstab J, Chasse R, Grabow P, Benzinger TL, Fagan AM, Xiong C, Jasielec M, Grant E, Morris JC. Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning. Neurobiology of Aging. 43: 23-33. PMID 27255812 DOI: 10.1016/J.Neurobiolaging.2016.03.014 |
0.517 |
|
| 2016 |
Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TL, et al. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease. Science Translational Medicine. 8: 338ra66. PMID 27169802 DOI: 10.1126/Scitranslmed.Aaf2362 |
0.502 |
|
| 2016 |
Ingber AP, Hassenstab J, Fagan AM, Benzinger TL, Grant EA, Holtzman DM, Morris JC, Roe CM. Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27104893 DOI: 10.3233/Jad-150478 |
0.527 |
|
| 2016 |
Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC. Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study. Neurology. PMID 27009258 DOI: 10.1212/Wnl.0000000000002593 |
0.459 |
|
| 2016 |
Hassenstab J, Chasse R, Grabow P, Benzinger TLS, Fagan AM, Xiong C, Jasielec M, Grant E, Morris JC. Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning Neurobiology of Aging. 43: 23-33. DOI: 10.1016/j.neurobiolaging.2016.03.014 |
0.427 |
|
| 2016 |
Petros J, Hassenstab J, Snitz BE, Zhou Y, Ringman JM, McDade E, Wang G, Balota DA, Aschenbrenner AJ, Benzinger TL, Cruchaga C, Fagan AM, Goate AM, Holtzman DM, Buckles V, et al. Dynamic Relationships Between “Big Five” Personality Traits, Alzheimer’S Disease Biomarkers, And Cognition In Autosomal Dominant Alzheimer’S Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.970 |
0.477 |
|
| 2016 |
Zhou Y, Bateman R, Hassenstab J, Snitz BE, Masters CL, Danek A, Laske C, Farlow MR, Ringman JM. Personality Characteristics And Alterations In Familial Alzheimer’S Disease In The Dominantly Inherited Alzheimer Network (Dian) Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.711 |
0.391 |
|
| 2016 |
McDade E, Weng H, Wang G, Xiong C, Fagan AM, Hassenstab J, Marcus DS, Morris JC, Benzinger TL, Cairns NJ, Goate AM, Buckles V, Holtzman DM, Berman S, Ghetti B, et al. O5-02-01: Longitudinal Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease: The Dominantly Inherited Alzheimer Network Alzheimer's & Dementia. 12: P378-P379. DOI: 10.1016/J.Jalz.2016.06.710 |
0.472 |
|
| 2016 |
Lim YY, Hassenstab J, Cruchaga C, Goate AM, Fagan AM, Lee Smith Benzinger T, Maruff P, Snyder PJ, Masters CL, Ricardo A, Chhatwal JP, Farlow MR, Graff-Radford NR, Laske C, Levin J, et al. F5-02-03: BDNF VAL66MET Moderates Cognitive Impairment, Neuronal Dysfunction and TAU in Preclinical Autosomal Dominant Alzheimer's Disease Alzheimer's & Dementia. 12: P369-P369. DOI: 10.1016/J.Jalz.2016.06.689 |
0.487 |
|
| 2016 |
Hassenstab J, Aschenbrenner AJ, Balota DA, Lim YY, McDade E, Wang G, Xiong C, Buckles V, Moulder KL, Paumier KL, Bateman R, Morris JC. Cognitive Trajectories In Dian: Relationships With Symptom Onset, Mutation Types, And Clinical Status Alzheimers & Dementia. 12: 368. DOI: 10.1016/J.Jalz.2016.06.687 |
0.347 |
|
| 2016 |
Buckles V, Xiong C, Weng H, Bateman R, Chhatwal JP, Ghetti B, Goate A, Graff-Radford NR, Hassenstab J, Mayeux R, Masters CL, McDade E, Moulder KL, Paumier KL, Ringman JM, et al. The Dian-Nacc Uds Comparison Study: Rates Of Cognitive Decline Alzheimers & Dementia. 12: 309. DOI: 10.1016/J.Jalz.2016.06.559 |
0.393 |
|
| 2016 |
Ances B, Brier MR, Gordon BA, Friedrichsen KA, McCarthy JE, Stern A, Christensen J, Owen CJ, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, et al. IC-P-179: TAU Imaging Relationships With Amyloid B Imaging, CSF TAU/AB42
, and Cognition in Alzheimer’s Disease Alzheimer's & Dementia. 12: P130-P131. DOI: 10.1016/J.Jalz.2016.06.210 |
0.426 |
|
| 2016 |
Gross AL, Johnson SC, Clark LR, Resnick SM, Moghekar A, Masters CL, Maruff P, Hassenstab J, Morris JC, Soldan A, Albert MS. P3-205: Development and Validation of an Algorithm for Diagnosing Preclinical Alzheimer’s Disease Across Five Cohorts Alzheimer's & Dementia. 12: P902-P903. DOI: 10.1016/J.Jalz.2016.06.1867 |
0.326 |
|
| 2015 |
Hassenstab J, Monsell SE, Mock C, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology. Journal of Neuropathology and Experimental Neurology. 74: 1086-92. PMID 26469250 DOI: 10.1097/Nen.0000000000000254 |
0.523 |
|
| 2015 |
Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/Wnl.0000000000001903 |
0.52 |
|
| 2015 |
Hassenstab J, Ruvolo D, Jasielec M, Xiong C, Grant E, Morris JC. Absence of Practice Effects in Preclinical Alzheimer's Disease. Neuropsychology. PMID 26011114 DOI: 10.1037/Neu0000208 |
0.509 |
|
| 2015 |
Wang L, Benzinger TL, Hassenstab J, Blazey T, Owen C, Liu J, Fagan AM, Morris JC, Ances BM. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease. Neurology. 84: 1254-60. PMID 25716355 DOI: 10.1212/Wnl.0000000000001401 |
0.556 |
|
| 2015 |
Monsell SE, Hassenstab J, Mock C, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological markers of cognitive decline in persons with Alzheimer’s disease neuropathology Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.291 |
0.489 |
|
| 2015 |
Hassenstab J, Standlee J, Cairns NJ, Morris JC. Neurofibrillary burden is a neuropathologic correlate of subjective cognitive decline Alzheimers & Dementia. 11: 563. DOI: 10.1016/J.Jalz.2015.06.725 |
0.424 |
|
| 2015 |
Day GS, Lim TS, Hassenstab J, Grant EA, Goate A, Morris JC, Cairns NJ. Differentiating corticobasal degeneration and Alzheimer disease by longitudinal clinical and cognitive features Alzheimers & Dementia. 11: 525. DOI: 10.1016/J.Jalz.2015.06.646 |
0.51 |
|
| 2015 |
Xiong C, Jasielec MS, Fagan AM, Benzinger TL, Head DM, Hassenstab J, Grant E, Buckles V, Moulder KL, Morris JC. P1-106: Longitudinal biomarker connectivity on middle-aged asymptomatic individuals and optimal design on prevention trials of Alzheimer's disease Alzheimer's & Dementia. 11: P379-P379. DOI: 10.1016/J.Jalz.2015.06.304 |
0.429 |
|
| 2015 |
Hassenstab J, Lim Y, Fagan AM, Ma S, Xiong C, Buckles V, Bateman R, Morris JC. CSF tau predicts working memory and global cognitive decline in autosomal dominant Alzheimer’s disease Alzheimers & Dementia. 11: 379. DOI: 10.1016/J.Jalz.2015.06.302 |
0.454 |
|
| 2015 |
Schindler SE, Jasielec MS, Xiong C, Fagan AM, Morris JC, Hassenstab J. P4-118: Neuropsychological determinants of stage 3 of preclinical Alzheimer disease Alzheimer's & Dementia. 11: P823-P823. DOI: 10.1016/J.Jalz.2015.06.1824 |
0.451 |
|
| 2015 |
Gordon BA, Hassenstab J, Fagan AM, Morris JC, Benzinger TL. IC-P-021: Lower body mass index is associated with greater Alzheimer pathology in asymptomatic individuals Alzheimer's & Dementia. 11: P25-P25. DOI: 10.1016/J.Jalz.2015.06.041 |
0.4 |
|
| 2014 |
Monsell SE, Mock C, Hassenstab J, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology. Neurology. 83: 434-40. PMID 24951474 DOI: 10.1212/Wnl.0000000000000650 |
0.515 |
|
| 2014 |
Brier MR, Thomas JB, Fagan AM, Hassenstab J, Holtzman DM, Benzinger TL, Morris JC, Ances BM. Functional connectivity and graph theory in preclinical Alzheimer's disease. Neurobiology of Aging. 35: 757-68. PMID 24216223 DOI: 10.1016/J.Neurobiolaging.2013.10.081 |
0.486 |
|
| 2014 |
Pizzie R, Hindman H, Roe CM, Head D, Grant E, Morris JC, Hassenstab JJ. Physical activity and cognitive trajectories in cognitively normal adults: the adult children study. Alzheimer Disease and Associated Disorders. 28: 50-7. PMID 23739296 DOI: 10.1097/Wad.0B013E31829628D4 |
0.326 |
|
| 2014 |
Hassenstab J, Aschenbrenner A, Balota D, Dreyfus DM, Bateman R, Morris JC. O4-12-06: COGNITIVE PERFORMANCE IN THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN): BASELINE AND PRELIMINARY LONGITUDINAL FINDINGS Alzheimer's & Dementia. 10: P277-P277. DOI: 10.1016/J.Jalz.2014.04.456 |
0.442 |
|
| 2013 |
Alosco ML, Gunstad J, Jerskey BA, Xu X, Clark US, Hassenstab J, Cote DM, Walsh EG, Labbe DR, Hoge R, Cohen RA, Sweet LH. The adverse effects of reduced cerebral perfusion on cognition and brain structure in older adults with cardiovascular disease. Brain and Behavior. 3: 626-36. PMID 24363966 DOI: 10.1002/Brb3.171 |
0.351 |
|
| 2013 |
Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. The Lancet. Neurology. 12: 957-65. PMID 24012374 DOI: 10.1016/S1474-4422(13)70194-7 |
0.544 |
|
| 2013 |
Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TL, Mintun MA, Holtzman DM, Morris JC. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology. 80: 1784-91. PMID 23576620 DOI: 10.1212/Wnl.0B013E3182918Ca6 |
0.524 |
|
| 2013 |
Ruvolo D, Chasse R, Dreyfus DM, Vernon E, Grant E, Morris J, Hassenstab J. Attenuation of practice effects on neuropsychological performance is a potential marker of preclinical Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.08.222 |
0.453 |
|
| 2013 |
Chasse R, Benzinger T, Grant E, Cairns N, Fagan A, Morris J, Hassenstab J. Alzheimer's disease biomarkers and normative cognitive data: The SuperNorms approach Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.08.220 |
0.529 |
|
| 2013 |
Wang L, Ercole L, Blazey T, Benzinger T, Hassenstab J, Morris J, Ances B. IC-P-114: A refined cortical signature of Alzheimer's disease Alzheimer's & Dementia. 9: P69-P69. DOI: 10.1016/J.Jalz.2013.05.111 |
0.4 |
|
| 2012 |
Pizzie R, Hindman H, Roe C, Head D, Grant E, Morris J, Hassenstab J. Physical Activity and Cognitive Trajectories in Cognitively Normal Middle-Aged and Elderly Adults: Longitudinal Findings from the Adult Children Study (S24.002) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S24.002 |
0.447 |
|
| 2011 |
Phelan S, Hassenstab J, McCaffery JM, Sweet L, Raynor HA, Cohen RA, Wing RR. Cognitive interference from food cues in weight loss maintainers, normal weight, and obese individuals. Obesity (Silver Spring, Md.). 19: 69-73. PMID 20539296 DOI: 10.1038/Oby.2010.138 |
0.303 |
|
| 2010 |
Bruehl H, Sweat V, Hassenstab J, Polyakov V, Convit A. Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance Journal of Clinical and Experimental Neuropsychology. 32: 487-493. PMID 20524222 DOI: 10.1080/13803390903224928 |
0.355 |
|
| 2009 |
Arentoft A, Sweat V, Starr V, Oliver S, Hassenstab J, Bruehl H, Tirsi A, Javier E, McHugh PF, Convit A. Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: evidence of a compensatory mechanism. Brain and Cognition. 71: 147-52. PMID 19481324 DOI: 10.1016/J.Bandc.2009.04.009 |
0.323 |
|
| 2007 |
Rogers K, Dziobek I, Hassenstab J, Wolf OT, Convit A. Who cares? Revisiting empathy in Asperger syndrome. Journal of Autism and Developmental Disorders. 37: 709-15. PMID 16906462 DOI: 10.1007/S10803-006-0197-8 |
0.336 |
|
| 2006 |
Dziobek I, Fleck S, Kalbe E, Rogers K, Hassenstab J, Brand M, Kessler J, Woike JK, Wolf OT, Convit A. Introducing MASC: a movie for the assessment of social cognition. Journal of Autism and Developmental Disorders. 36: 623-36. PMID 16755332 DOI: 10.1007/S10803-006-0107-0 |
0.349 |
|
| 2006 |
Wang G, Xiong C, McDade E, Li Y, Aschenbrenner AJ, Hassenstab J, Berry S, Bateman RJ. P2-076: A NOVEL ALTERNATIVE MODEL TO MMRM AS THE PRIMARY MODEL FOR SPORADIC AD CLINICAL TRIALS: THE PROPORTIONAL MMRM Alzheimer's & Dementia. 14: P696-P696. DOI: 10.1016/J.Jalz.2018.06.761 |
0.332 |
|
| 2006 |
Li Y, Wang G, Xiong C, McDade E, Fagan AM, Gordon BA, Benzinger TL, Aschenbrenner AJ, Hassenstab J, Bateman RJ. P2-072: A STATISTICAL METHOD FOR DETERMINING BIOMARKER THRESHOLD FOR ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P694-P695. DOI: 10.1016/J.Jalz.2018.06.757 |
0.452 |
|
| 2006 |
Buckles VD, Xiong C, Beckett L, Benzinger TL, Fagan AM, Shaw LM, Hassenstab J, Coble DW, Toga AW, Carrillo MC, Weninger S, Bateman RJ, Weiner M, Morris JC. P1-288: THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN)-ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI) COMPARISON STUDY: CHALLENGES AND OPPORTUNITIES Alzheimer's & Dementia. 14: P395-P396. DOI: 10.1016/J.Jalz.2018.06.294 |
0.488 |
|
| 2006 |
Fagan AM, Li Y, Todd K, Herries EM, Henson RL, Schindler SE, Gray JD, Wang G, Graham D, Fields L, Shaw LM, Ladenson JH, Hassenstab J, Benzinger TL, Morris JC, et al. O3-14-01: NOVEL CSF BIOMARKERS OF NEURONAL INJURY, SYNAPTIC DYSFUNCTION AND NEUROINFLAMMATION IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE: VILIP-1, NEUROGRANIN, SNAP-25 AND YKL-40 IN THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN) Alzheimer's & Dementia. 14: P1059-P1059. DOI: 10.1016/J.Jalz.2018.06.2849 |
0.401 |
|
| 2006 |
Roe CM, Babulal GM, Fagan AM, Benzinger TL, Stout SH, Hassenstab J, Gordon BA, Holtzman DM, Morris JC, Ances BM. O2-15-02: LONGITUDINAL COURSE OF PRECLINICAL AD USING THE A/T/N FRAMEWORK Alzheimer's & Dementia. 14: P660-P661. DOI: 10.1016/J.Jalz.2018.06.2725 |
0.313 |
|
| 2006 |
Harrington KD, Hassenstab J, Maruff P, Masters CL, Aschenbrenner AJ, Fagan AM, Benzinger TL, Cruchaga C, Morris JC. P3-494: EXAMINING THE INFLUENCE OF UNDETECTED ATN NEUROPATHOLOGY ON COGNITIVE AGING TRAJECTORIES Alzheimer's & Dementia. 14: P1311-P1311. DOI: 10.1016/J.Jalz.2018.06.1858 |
0.408 |
|
| 2006 |
Xiong C, Buckles VD, McCue L, Coble DW, Beckett L, Weiner M, Shaw LM, McDade E, Fagan AM, Benzinger TL, Hassenstab J, Bateman RJ, Morris JC. P3-213: MORE POWERFUL STATISTICAL APPROACHES FOR LONGITUDINAL COMPARISONS OF AD SUBTYPES ON CSF AND IMAGING BIOMARKERS FROM DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN) AND ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI) Alzheimer's & Dementia. 14: P1152-P1152. DOI: 10.1016/J.Jalz.2018.06.1572 |
0.48 |
|
| 2006 |
Wang G, Xiong C, McDade E, Li Y, Aschenbrenner AJ, Hassenstab J, Fagan AM, Gordon BA, Benzinger TL, Morris JC, Bateman RJ. P1-119: CROSS-SECTIONAL AND LONGITUDINAL RELATIONSHIPS AMONG BIOMARKERS FOR DOMINANTLY INHERITED ALZHEIMER'S DISEASE AND ITS COMPARISON WITH SPORADIC AD Alzheimer's & Dementia. 14: P316-P316. DOI: 10.1016/J.Jalz.2018.06.122 |
0.477 |
|
| Show low-probability matches. |